Quest Diagnostics (DGX) Other Non-Current Assets (2009 - 2026)
Quest Diagnostics' (DGX) quarterly Other Non-Current Assets came in at $256.0 million in Q1 2026, down 1.54% year-on-year from $260.0 million in Q1 2025, and down 5.19% quarter-over-quarter from $270.0 million in Q4 2025.
Quest Diagnostics (DGX) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Quest Diagnostics has disclosed Other Non-Current Assets across 18 years of filings, most recently posting $256.0 million for Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $256.0 million, down 1.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $256.0 million (down 1.54% YoY), and the FY2025 annual result was $270.0 million, up 5.88% from the prior year.
- Other Non-Current Assets came in at $256.0 million for Q1 2026 at Quest Diagnostics, down from $270.0 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $296.0 million in Q3 2025 to a low of $132.0 million in Q3 2022.
- The 5-year median for Other Non-Current Assets is $198.0 million (2023), against an average of $205.6 million.
- Across the five-year window, Other Non-Current Assets slipped 22.16% in 2022 and jumped 82.55% in 2024, its largest moves.
- Quest Diagnostics' Other Non-Current Assets stood at $144.0 million in 2022, then surged by 37.5% to $198.0 million in 2023, then gained by 28.79% to $255.0 million in 2024, then rose by 5.88% to $270.0 million in 2025, then retreated by 5.19% to $256.0 million in 2026.
- The last three Other Non-Current Assets figures came in at $256.0 million (Q1 2026), $270.0 million (Q4 2025), and $296.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 498.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 5.97 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 4.21 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 552.79 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 1.18 Bn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 51.00 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 489.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 523.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 454.16 Mn |
| 10 | Quest Diagnostics | 22.51 Bn | 22.42 Bn | 942.00 Mn | 256.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 256.00 Mn |
| Dec 31, 2025 | 270.00 Mn |
| Sep 30, 2025 | 296.00 Mn |
| Jun 30, 2025 | 271.00 Mn |
| Mar 31, 2025 | 260.00 Mn |
| Dec 31, 2024 | 255.00 Mn |
| Sep 30, 2024 | 272.00 Mn |
| Jun 30, 2024 | 216.00 Mn |
| Mar 31, 2024 | 182.00 Mn |
| Dec 31, 2023 | 198.00 Mn |
| Sep 30, 2023 | 149.00 Mn |
| Jun 30, 2023 | 152.00 Mn |
| Mar 31, 2023 | 150.00 Mn |
| Dec 31, 2022 | 144.00 Mn |
| Sep 30, 2022 | 132.00 Mn |
| Jun 30, 2022 | 137.00 Mn |
| Mar 31, 2022 | 155.00 Mn |
| Dec 31, 2021 | 163.00 Mn |
| Sep 30, 2021 | 155.00 Mn |
| Jun 30, 2021 | 176.00 Mn |